检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Wai Ki Wong Bohan Yin Anel Rakhmatullina Jingying Zhou Siu Hong Dexter Wong
机构地区:[1]Department of Bioengineering,Imperial College London,London SW72AZ,United Kingdom [2]Department of Biomedical Engineering,The Hong Kong Polytechnic University,Kowloon,Hong Kong,China [3]School of Biomedical Sciences,The Chinese University of Hong Kong,Shatin,Hong Kong,China
出 处:《Engineered Regeneration》2021年第1期70-81,共12页再生工程(英文)
基 金:the start-up funding(A0033912)from the Department of Biomedical Engineering;Start-up Fund for RAPs under the Strategic Hiring Scheme(0035876);the Hong Kong Polytechnic University(University Grant Council),for supporting this work.
摘 要:Adoptive T-cell therapy(ACT)is a promising therapeutic approach based on the concept of potent T-cell mediated immunity against the tumor.The outcome of antigen-specific T-cells responses relies on the interaction between T-cells and antigen-presenting cells,which provides signals for generating different T-cell phenotypes with different roles in tumor removal.However,such interaction is often not optimal in vivo and results in low therapeutic efficacy.To reach the full potential of the T-cell response,current research put effort into developing dynamic biomaterials as artificial antigen-presenting cells to study and regulate the T-cell activity for controlling T-cell fate.In this perspective,we provide(1)an overview of ACT and general T-cells behaviors,(2)explore the insight on how biomaterials can be used for studying and regulating T-cell behaviors,(3)and discuss conceptual gaps in knowledge for biomaterials-based immunotherapy.
关 键 词:T-cell mechanobiology Dynamic nanobiomaterials Adoptive T-cell immunotherapy T-Ligand presentation
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249